TRXB · Forms 3, 4, 5
Insider trades at TRex Bio
2 insiders bought $3.8M of TRex Bio stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for TRex Bio (TRXB) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Alexandria Venture Investments, LLC | 10% owner | Conversion | 1,167,930 | Form 4 | |||
| Alexandria Venture Investments, LLC | 10% owner | Buy | 178,571 | $14.00 | $2.5M | Form 4 | |
| Joel S Marcus | Director | Conversion | 41,871 | Form 4 | |||
| SVLSF VI, LLC | 10% owner | Conversion | 1,574,074 | Form 4 | |||
| SVLSF VI, LLC | 10% owner | Conversion | 475,411 | Form 4 | |||
| SVLSF VI, LLC | 10% owner | Conversion | 53,892 | Form 4 | |||
| SVLSF VI, LLC | 10% owner | Conversion | 16,277 | Form 4 | |||
| SVLSF VI, LLC | 10% owner | Conversion | 669,939 | Form 4 | |||
| SVLSF VI, LLC | 10% owner | Buy | 89,783 | $14.00 | $1.3M | Form 4 | |
| SVLSF VI, LLC | 10% owner | Buy | 3,074 | $14.00 | $43K | Form 4 | |
| SVLSF VI, LLC | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| Joel S Marcus | Director | Options or other derivatives | Form 4 | ||||
| Travis Alan Coy | Director | Options or other derivatives | Form 4 | ||||
| Michael Jay Ross | Director | Options or other derivatives | Form 4 | ||||
| Peter Hirth | Director | Options or other derivatives | Form 4 | ||||
| Carol Giltner Gallagher | Director | Options or other derivatives | Form 4 | ||||
| Julie Ann Gilmore | Director | Options or other derivatives | Form 4 | ||||
| Peter Hirth | Director | Became an insider (Form 3) | Form 3 | ||||
| Michael Jay Ross | Director | Became an insider (Form 3) | Form 3 | ||||
| Laura Berner | Chief Operating Officer | Became an insider (Form 3) | Form 3 | ||||
| Brandon Hants | Chief Financial Officer | Became an insider (Form 3) | Form 3 | ||||
| Travis Alan Coy | Director | Became an insider (Form 3) | Form 3 | ||||
| Julie Ann Gilmore | Director | Became an insider (Form 3) | Form 3 | ||||
| Ali Zarrin | Chief Scientific Officer | Became an insider (Form 3) | Form 3 | ||||
| Marion Johnston Erwin Jr. | Chief Executive Officer | Became an insider (Form 3) | Form 3 | ||||
| Carol Giltner Gallagher | Director | Became an insider (Form 3) | Form 3 | ||||
| Joel S Marcus | Director | Became an insider (Form 3) | Form 3 | ||||
| Ariella Kelman | Chief Medical Officer | Became an insider (Form 3) | Form 3 | ||||
| ELI LILLY & Co | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| Alexandria Venture Investments, LLC | 10% owner | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.